Non-viral Gene Therapy - Intracellular Delivery: Fundamentals and Applications - page 685

Kircheis, R., Kichler, A., Wallner, G., Kursa, M., Ogris, M., Felzmann, T., Buchberger, M. &
Wagner, E. (1997) Coupling of cell-binding ligands to polyethylenimine for targeted gene
delivery. Gene Ther. , 4, 409-418.
Kircheis, R., Schuller, S., Brunner, S., Ogris, M., Heider, K. H., Zauner, W. & Wagner, E. (1999)
Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J. Gene Med. , 1,
111-120.
Kircheis, R., Wightman, L., Schreiber, A., Robitza, B., Rossler, V., Kursa, M. & Wagner, E.
(2001a) Polyethylenimine/DNA complexes shielded by transferrin target gene expression to
tumors after systemic application. Gene Ther. , 8, 28-40.
Kircheis, R., Wightman, L. & Wagner, E. (2001b) Design and gene delivery activity of modified
polyethylenimines. Adv. Drug Deliv. Rev. , 53, 341-358.
Kishida, T., Asada, H., Itokawa, Y., Yasutomi, K., Shin-Ya, M., Gojo, S., Cui, F. D., Ueda, Y.,
Yamagishi, H., Imanishi, J. & Mazda, O. (2003) Electrochemo-gene therapy of cancer:
Intratumoral delivery of Interleukin-12 gene and bleomycin synergistically induced therapeu-
tic immunity and suppressed subcutaneous and metastatic melanomas in mice. Mol. Ther. , 8,
738-745.
Klumpp, C., Kostarelos, K., Prato, M. & Bianco, A. (2006) Functionalized carbon nanotubes as
emerging nanovectors for the delivery of therapeutics. Biochim. Biophys. Acta. , 1758,
404-412.
Kneuer, C., Sameti, M., Haltner, E. G., Schiestel, T., Schirra, H., Schmidt, H. & Lehr, C. M.
(2000) Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA. Int. J.
Pharm. , 196, 257-261.
Ko, K. S., Lee, M., Koh, I. J. & Kim, S. W. (2001) Combined administration of plasmids encoding
IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice.
Mol. Ther. , 4, 313-316.
Ko, Y. T., Falcao, C. & Torchilin, V. P. (2009a) Cationic liposomes loaded with proapoptotic
peptide D-(KLAKLAK)(2) and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced
anticancer therapy Mol. Pharm. , 6, 971-977.
Ko, Y. T., Hartner, W. C., Kale, A. A. & Torchilin, V. P. (2009b) Gene delivery into ischemic
myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide. Gene
Ther. , 16, 52-59.
Kogure, K., Akita, H., Yamada, Y. & Harashima, H. (2008) Multifunctional envelope-type nano
device (MEND) as a non-viral gene delivery system. Adv. Drug Deliv. Rev. , 60, 559-571.
Koh, I. J., Ko, K. S., Lee, M., Han, S., Park, J. S. & Kim, S. W. (2000) Degradable polymeric
carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice.
Gene Ther. , 7, 2099-2104.
Kono, K., Akiyama, H., Takahashi, T., Takagishi, T. & Harada, A. (2005) Transfection activity of
polyamidoamine dendrimers having hydrophobic amino acid residues in the periphery
Bioconjugate Chem. , 16, 208-214.
Konstan, M. W., Davis, P. B., Wagener, J. S., Hilliard, K. A., Stern, R. C., Milgram, L. J. H.,
Kowalczyk, T. H., Hyatt, S. L., Fink, T. L., Gedeon, C. R., Oette, S. M., Payne, J. M.,
Muhammad, O., Ziady, A. G., Moen, R. C. & Cooper, M. J. (2004) Compacted DNA nanopar-
ticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate
partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum. Gene Ther. ,
15, 1255-1269.
Kopatz, I., Remy, J. S. & Behr, J. P. (2004) A model for non-viral gene delivery: through syndecan
adhesion molecules and powered by actin J. Gene Med. , 6, 769-776.
Kornguth, S. E. & Stahmann, M. A. (1961) Effect of polylysine on the leakage and retention of
compounds by Ehrlich ascites tumor cells. Cancer Res. , 21, 907-912.
Koynova, R. & Tenchov, B. (2009) Cationic phospholipids: structure-transfection activity rela-
tionships. Soft Matter , 5, 3187-3200.
Krajcik, R., Jung, A., Hirsch, A., Neuhuber, W. & Zolk, O. (2008) Functionalization of carbon
nanotubes enables non-covalent binding and intracellular delivery of small interfering RNA for
efficient knock-down of genes. Biochem. Biophys. Res. Commun. , 369, 595-602.